A detailed history of River Park Advisors, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, River Park Advisors, LLC holds 3,192 shares of PRCT stock, worth $242,655. This represents 0.21% of its overall portfolio holdings.

Number of Shares
3,192
Previous 2,211 44.37%
Holding current value
$242,655
Previous $135,000 88.89%
% of portfolio
0.21%
Previous 0.11%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$56.31 - $84.99 $55,240 - $83,375
981 Added 44.37%
3,192 $255,000
Q2 2024

Jul 26, 2024

BUY
$45.73 - $69.19 $101,109 - $152,979
2,211 New
2,211 $135,000

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $3.39B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track River Park Advisors, LLC Portfolio

Follow River Park Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of River Park Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on River Park Advisors, LLC with notifications on news.